PHE at AMCP 2018

Precision Health Economics was excited to participate in AMCP, taking place this year in Boston from April 23-26.

For a complete list of Precision’s scientific presentations, please see below:

Education Sessions:

4/24/2018, 9:50 AM – 11:05 AM
New Tools for Measuring Treatment Value in Rheumatoid Arthritis
Jeffrey Curtis, MD, MS, MPH; Jeroen P. Jansen, PhD; Jason Shafrin, PhD

 4/25/2018, 8:30 AM – 9:45 AM
Charting the Shifting Value-Based Healthcare Landscape: Emerging Developments for 2018 and Beyond
Jorge Font, MPH; Elizabeth Oyekan, PharmD, FCSHP, CPHQ

 4/25/2018, 3:00 PM – 4:15 PM
From Europe to the U.S.: The Challenge and Potential of Gene Therapies
Alex Grosvenor; Jeremy Schafer, PharmD, MBA

 4/26/2018, 11:15 AM – 12:30 PM
Motivational Interviewing: Improving Outcomes Through Enhanced Motivation
Maureen Hennessey, PhD, CPCC; Elizabeth Oyekan, PharmD, FCSHP, CPHQ


4/25/2018, 12:30PM – 2:30PM (Author Presentations)
“The Economic Burden of Switching Targeted Disease Modifying Anti-Rheumatic Drugs Among Rheumatoid Arthritis Patients: A Comparison Between Tumor Necrosis Factor Inhibitors and Abatacept ”
Authors: A Shahabi, L Zhao, S Green, J Shafrin, P Damemarie, A Marshall, T Curtice,
Presenter: Jason Shafrin

“Comparison of Health Resource Utilization for Multiple-Daily Injections (MDI) with Basal and Bolus Insulin Therapy Versus Non-MDI Therapy in Patients with Type 2 Diabetes”
Authors: Ludden T, Philips S, Taylor S, Ermakova A, Cyr PL, Xiong Y, Sieradzan R, Sacks N


Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.